Showing results (501-510 of 667) with videos related to
Sort By:
Pageof 67
Current Problems in Cancer|June 10, 2022
Optimizing the use of adjuvant chemotherapy in non-small cell lung cancer patients with comorbiditiesStacyann Bailey, Qian Wang, Chung Yin Kong, et al.Current Problems in Cancer|June 10, 2022
Evaluation and external validation of minor lymphatic pelvic pathway for distant metastases in cervical cancer patients treated with concurrent chemoradiotherapyKullathorn Thephamongkhol, Pornpim Korpraphong, Kobkun Muangsomboon, et al.Current Problems in Cancer|October 31, 2020
Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literatureRukiye Arıkan, Tuğba Akın Telli, Nazım Can Demircan, et al.Current Problems in Cancer|October 31, 2020
A comparative study of cyclophosphamide, thalidomide and dexamethasone (CTD) versus bortezomib and dexamethasone (BDex) in light-chain amyloidosisBaojian Liu, Yan Wang, Xiaoxuan Ning, et al.Current Problems in Cancer|June 20, 2017
Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experienceChih-Jian Lih, Naoko TakebeCurrent Problems in Cancer|February 18, 2022
Comparison of mutational profiles between triple-negative and hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancers in T2N0-1M0 stage: Implications of TP53 and PIK3CA mutations in Korean early-stage breast cancersSeungju Lee, Hyun Yul Kim, Youn Joo Jung, et al.Current Problems in Cancer|December 9, 2023
The diagnostic value of serum lncRNA CATG00000112921.1 as a marker of multiple myelomaJing Gao, Jing Qu, Bin Xiao, et al.Current Problems in Cancer|November 5, 2023
Changing trends in disease burden of lung cancer in China from 1990-2019 and following 15-year predictionDi Zhao, Jinzhi Lu, Wen Zeng, et al.Current Problems in Cancer|September 17, 2023
Prognostic role of the peritoneal cancer index in ovarian cancer patients who undergo cytoreductive surgery: a meta-analysisShu-Li Yang, Li-Hui Si, Rui-Xin Lin, et al.Current Problems in Cancer|September 13, 2023
Impact of non-BRCA genes in the indication of risk-reducing surgery in hereditary breast and ovarian cancer syndrome (HBOC)Laura Fernández Madrigal, Maria Yeray Rodríguez Garcés, Francisco Javier Jiménez RuizPageof 67